Our proteomics data reveal that complement activation is a core component of the overreaction of the immune system in response to COVID-19 (Fig. 3b), with elevated MBL2 being a predictor of 28-day ICU mortality (Fig. 3d). Here, MBL2 is linked to COVID-19.